Role of MRD in treatment decisions for AML: Latest insights from ASH 2023
Here, we summarize presentations from ASH 2023 by Russel.1, Othman.2,4, Loo.3, and Gui.5,6 discussing the prognostic utility of measurable residual disease in patients with AML.